Gate News bot message, MEI Pharma has announced its acquisition of Litecoin (LTC) as part of a $100 million institutional treasury strategy. The pharmaceutical company is receiving strategic guidance from Litecoin founder Charlie Lee and digital asset trading firm GSR for this cryptocurrency initiative. Source: BWENEWS AI
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
MEI Pharma Expands into Crypto with $100M Litecoin Treasury Strategy
Gate News bot message, MEI Pharma has announced its acquisition of Litecoin (LTC) as part of a $100 million institutional treasury strategy. The pharmaceutical company is receiving strategic guidance from Litecoin founder Charlie Lee and digital asset trading firm GSR for this cryptocurrency initiative. Source: BWENEWS AI